Diagnostic performance and accuracy of 3-d spoiled gradient-dual-echo mri with water-and fat-signal separation in liver-fat quantification: Comparison to liver biopsy

Investigative Radiology

Volumn 45, Issue 8, 2010, Pages 465-470

  Fischer, Michael A ^a   Nanz, Daniel ^a   Reiner, Caecilia S ^a   Montani, Matteo ^a   Breitenstein, Stefan ^a   Leschka, Sebastian ^a   Alkadhi, Hatem ^a   Stolzmann, Paul ^a   Marincek, Borut ^a   Scheffel, Hans ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

3D spoiled gradient dual echo magnetic resonance imaging; IP OP imaging; Liver fat content

Indexed keywords

FAT; WATER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FAT CONTENT; FATTY LIVER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIPID ANALYSIS; LIVER BIOPSY; LIVER SURGERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STEATOSIS; THREE DIMENSIONAL IMAGING;

EID: 77954757826     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181da1343     Document Type: Article

References (31)

1. Schwimmer JB, Deutsch R, Kahen T, et al. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388-1393.
2. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
3. Hjelkrem MC, Torres DM, Harrison SA. Nonalcoholic fatty liver disease. Minerva Med. 2008;99:583-593.
4. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221-1231.
5. McCormack L, Petrowsky H, Jochum W, et al. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007;245:923-930.
6. Kooby D, Fong Y, Gonen M, et al. Hepatic steatosis is associated with increased complications following major liver resection for cancer but does not impact survival. Gastroenterology. 2003;124:A794-A794.
7. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344:495-500.
8. McGill DB, Rakela J, Zinsmeister AR, et al. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology. 1990;99: 1396-1400.
9. Mehta SR, Thomas EL, Bell JD, et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476-3483.
10. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol. 2008;43:330-337.
11. Kim HJ, Byun JH, Park SH, et al. Focal fatty replacement of the pancreas: usefulness of chemical shift MRI. Am J Roentgenol. 2007;188:429-432.
12. Cowin GJ, Jonsson JR, Bauer JD, et al. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging. 2008;28: 937-945.
13. Ma J. Breath-hold water and fat imaging using a dual-echo two-point Dixon technique with an efficient and robust phase-correction algorithm. Magn Reson Med. 2004;52:415-419.
14. Ma J, Vu AT, Son JB, et al. Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI. J Magn Reson Imaging. 2006;23:36-41.
15. Westphalen AC, Qayyum A, Yeh BM, et al. Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology. 2007; 242:450-455.
16. Couinaud C. Liver anatomy: portal (and suprahepatic) or biliary segmentation. Dig Surg. 1999;16:459-467.
17. El-Badry AM, Moritz W, Contaldo C, et al. Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology. 2007;45:855-863.
18. Borra RJ, Salo S, Dean K, et al. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging. Radiology. 2009;250:130-136.
19. Kim SH, Lee JM, Han JK, et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging\-correlation with his-topathologic findings. Radiology. 2006;240:116-129.
20. Mason D. Pydicom: a pure python package for working with DICOM files. 2009. Available at: http://pypi.python.org/pypi/pydicom/. Accessed September 5, 2009.
21. Qayyum A, Goh JS, Kakar S, et al. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques\initial experience. Radiology. 2005;237:507-511.
22. Machann J, Thamer C, Schnoedt B, et al. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med. 2006;55:913-917.
23. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging. 1995;5:281-285.
24. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1. 5 T vs.biopsy. Am J Roentgenol. 1991;156:307-312.
25. Mitchell DG, Kim I, Chang TS, et al. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol. 1991;26:1041-1052.
26. Marin D, Soher BJ, Dale BM, et al. Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T\prelimi-nary results. Radiology. 2010;254:179-187.
27. Mennesson N, Dumortier J, Hervieu V, et al. Liver steatosis quantification using magnetic resonance imaging: a prospective comparative study with liver biopsy. J Comput Assist Tomogr. 2009;33:672-677.
28. Roullier V, Cavaro-Menard C, Guillaume C, et al. Fuzzy algorithms to extract vacuoles of steatosis on liver histological color images. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5575-5578.
29. El-Badry AM, Breitenstein S, Jochum W, et al. Assessment of hepatic steatosis by expert pathologists: the end of a gold standard. Ann Surg. 2009;250:691-697.
30. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001;21:105-113.
31. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64:248-251.